# BioSpectra, Inc. – FDA Inspection, Aug 1, 2017

Source: https://www.keypedia.com/records/fda_inspections/biospectra-inc/c9c09085-d24b-4a4a-9a46-4801c63fbbef
Source feed: FDA_Inspections

> FDA inspection 1021136 of BioSpectra, Inc., August 01, 2017. Classification: No Action Indicated (NAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1021136
- Company Name: BioSpectra, Inc.
- Inspection Date: 2017-08-01
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1232448 - 2024-02-02](https://www.keypedia.com/records/fda_inspections/biospectra-inc/f7f20e74-376a-4b92-9934-867dde25da63)
- FDA Inspection 1142678 - 2021-05-04
- FDA Inspection 957613 - 2016-01-29
- [FDA Inspection 916696 - 2015-03-05](https://www.keypedia.com/records/fda_inspections/biospectra-inc/bb56058b-2f13-4eeb-bf18-99d53d3719ec)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/niketa-patel/73efe456-da61-4345-8dec-7147b12b88d1)

Company: https://www.keypedia.com/companies/biospectra-inc/ffb13a38-4f04-49cb-a6fe-fd55f544fcf0

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
